VIR
Vir Biotechnology, Inc.
9.95
3 x 7.17
2 x 10.29
bid
ask
+
0.39
4.07%
11:24 AM
timesize
| Ytd | 65.00% | |
| 1y | 83.23% |
9.59
day range
10.10
4.16
52 week range
11.66
| Open | 9.64 | Prev Close | 9.56 | Low | 9.59 | High | 10.10 | Mkt Cap | 1.68B |
| Vol | 283.61K | Avg Vol | 1.93M | EPS | -3.13 | P/E | N/A | Forward P/E | -4.11 |
| Beta | 1.64 | Short Ratio | 11.13 | Inst. Own | 80.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.45 | 200-d Avg | 7.65 | 1yr Est | 21.56 |
| Income Statement | |||
| Total Revenue | -29.00K | ||
| Revenues (USD) | -29.00K | ||
| Gross Profit | -29.00K | ||
| Operating Expenses | 132.26M | ||
| Research and Development Expense | 108.92M | ||
| Selling, General and Administrative Expense | 23.34M | ||
| Operating Income | -132.29M | ||
| Income Tax Expense | 170.00K | ||
| Net Income | -125.69M | ||
| Net Income Common Stock | -125.69M | ||
| Net Income Common Stock (USD) | -125.69M | ||
| Consolidated Income | -125.69M | ||
| Earnings per Basic Share | -0.85 | ||
| Earnings per Basic Share (USD) | -0.85 | ||
| Earnings per Diluted Share | -0.85 | ||
| Earning Before Interest & Taxes (EBIT) | -125.52M | ||
| Earning Before Interest & Taxes (USD) | -125.52M | ||
| Weighted Average Shares | 147.36M | ||
| Weighted Average Shares Diluted | 147.36M | ||
| Balance Sheet | |||
| Cash and Equivalents | 276.09M | ||
| Cash and Equivalents (USD) | 276.09M | ||
| Investments | 542.06M | ||
| Investments Current | 202.14M | ||
| Investments Non-Current | 339.93M | ||
| Current Assets | 522.99M | ||
| Property, Plant & Equipment Net | 113.92M | ||
| Total Assets | 1.03B | ||
| Total Debt | 86.64M | ||
| Current Liabilities | 73.56M | ||
| Debt Non-Current | 86.64M | ||
| Total Liabilities | 212.82M | ||
| Accumulated Retained Earnings (Deficit) | -1.32B | ||
| Accumulated Other Comprehensive Income | -3.48M | ||
| Shareholders Equity | 812.77M | ||
| Shareholders Equity (USD) | 812.77M | ||
| Assets Non-Current | 502.60M | ||
| Total Debt (USD) | 86.64M | ||
| Goodwill and Intangible Assets | 24.71M | ||
| Liabilities Non-Current | 139.26M | ||
| Trade and Non-Trade Payables | 5.45M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.15M | ||
| Net Cash Flow from Financing | 162.52M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 41.97M | ||
| Capital Expenditure | -390.00K | ||
| Issuance (Purchase) of Equity Shares | 162.52M | ||
| Net Cash Flow from Investing | 11.84M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.23M | ||
| Net Cash Flow from Operations | -132.39M | ||
| Share Based Compensation | 12.09M | ||